Alkermes Plc (ALKS)
48.85
+0.52
(+1.08%)
USD |
NASDAQ |
Aug 24, 16:00
48.85
0.00 (0.00%)
After-Hours: 20:00
Alkermes Enterprise Value : 9.013B for Aug. 21, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 9.013B |
| August 20, 2026 | 8.961B |
| August 19, 2026 | 9.323B |
| August 18, 2026 | 9.206B |
| August 17, 2026 | 9.268B |
| August 14, 2026 | 9.136B |
| August 13, 2026 | 9.201B |
| August 12, 2026 | 9.340B |
| August 11, 2026 | 9.161B |
| August 10, 2026 | 9.193B |
| August 07, 2026 | 9.154B |
| August 06, 2026 | 9.020B |
| August 05, 2026 | 9.228B |
| August 04, 2026 | 9.238B |
| August 03, 2026 | 9.214B |
| July 31, 2026 | 9.124B |
| July 30, 2026 | 9.298B |
| July 29, 2026 | 9.015B |
| July 28, 2026 | 9.377B |
| July 27, 2026 | 9.750B |
| July 24, 2026 | 9.777B |
| July 23, 2026 | 9.791B |
| July 22, 2026 | 9.725B |
| July 21, 2026 | 9.771B |
| July 20, 2026 | 9.581B |
| Date | Value |
|---|---|
| July 17, 2026 | 9.749B |
| July 16, 2026 | 9.618B |
| July 15, 2026 | 9.625B |
| July 14, 2026 | 9.561B |
| July 13, 2026 | 9.606B |
| July 10, 2026 | 9.618B |
| July 09, 2026 | 9.926B |
| July 08, 2026 | 10.01B |
| July 07, 2026 | 10.17B |
| July 06, 2026 | 10.15B |
| July 02, 2026 | 10.06B |
| July 01, 2026 | 9.581B |
| June 30, 2026 | 9.694B |
| June 29, 2026 | 9.814B |
| June 26, 2026 | 10.24B |
| June 25, 2026 | 9.864B |
| June 24, 2026 | 9.468B |
| June 23, 2026 | 9.072B |
| June 22, 2026 | 8.730B |
| June 18, 2026 | 8.559B |
| June 17, 2026 | 8.479B |
| June 16, 2026 | 8.409B |
| June 15, 2026 | 8.454B |
| June 12, 2026 | 8.441B |
| June 11, 2026 | 8.547B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Amarin Corp. Plc | -13.67M |
| Jazz Pharmaceuticals Plc | 18.69B |
| Prothena Corp. Plc | 207.78M |
| ACADIA Pharmaceuticals, Inc. | 4.195B |
| Biogen, Inc. | 39.09B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 0.501M |
| Revenue (Quarterly) | 496.01M |
| Total Expenses (Quarterly) | 495.51M |
| EPS Diluted (Quarterly) | 0.0029 |
| Gross Profit Margin (Quarterly) | 75.30% |
| Profit Margin (Quarterly) | 0.10% |
| Earnings Yield | 0.79% |
| Operating Earnings Yield | 1.74% |
| Normalized Earnings Yield | 1.006 |